Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 914
interventional 789
Observational 116
Registry 9

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 257
Behavioral 221
Drug|placebo 123
Other 57
Behavioral|Other 28
Device 26
Behavioral|Drug 18
Dietary Supplement|placebo 9
Drug|Other 6
Procedure 6
Behavioral|Device 4
Behavioral|Drug|placebo 4
Dietary Supplement 4
Device|placebo 3
Behavioral|Drug|Other 2
Behavioral|Procedure 2
Biological 2
Combination Product 2
Drug|Other|placebo 2
Behavioral|Biological|Diagnostic Test 1
Behavioral|Drug|placebo|Radiation 1
Behavioral|Drug|Procedure 1
Behavioral|placebo 1
Combination Product|Diagnostic Test 1
Device|Drug 1
Device|Other 1
Diagnostic Test 1
Dietary Supplement|Drug 1
Drug|Procedure 1
Genetic|Other 1
NA 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 384
NA 73
Canada 48
Germany 25
United Kingdom 23
Spain 21
Australia 17
Taiwan 13
Denmark 11
Hong Kong 11
Sweden 11
Norway 10
France 9
Korea, Republic of 8
United States|Canada 8
China 7
Pakistan 7
India 5
Belgium 4
Brazil 4
Finland 4
Israel 4
Switzerland 4
Ireland 3
Netherlands 3
Austria 2
Ethiopia 2
Israel|Romania 2
Italy 2
Mexico 2
Moldova, Republic of 2
South Africa 2
Tanzania 2
Argentina 1
Australia|Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Romania|Spain|Switzerland|United Kingdom 1
Australia|Belgium|Brazil|Croatia|Czech Republic|Mexico|Slovakia|Spain 1
Austria|Germany|Israel|Italy|Netherlands|Norway|Spain|Switzerland|United Kingdom 1
Austria|Norway 1
Bangladesh 1
Belgium|Netherlands 1
Brazil|Chile 1
Brazil|Pakistan 1
Bulgaria|Croatia|Former Serbia and Montenegro|Romania 1
Bulgaria|Croatia|Romania|Serbia 1
Canada|Russian Federation 1
Canada|United Kingdom 1
Chile 1
Colombia 1
Croatia|United States|Argentina|Brazil|Chile|Israel|South Africa|Thailand 1
Czechia|Germany 1
Denmark|Finland|Iceland|Switzerland 1
Egypt 1
Egypt|Greece|Jordan|Kuwait|Lebanon|Saudi Arabia|South Africa|Turkey|United Arab Emirates 1
Germany|Spain|Brazil|Bulgaria|United States|Argentina|Belgium 1
Ghana 1
Ghana|Nigeria 1
Ireland|Israel|Latvia|Lithuania|Poland|Portugal|Romania|Austria|Bulgaria|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Greece|Hungary|Saudi Arabia|Slovakia|Slovenia|Spain|Sweden|Turkey|United Kingdom 1
Mozambique 1
Poland|Romania|United Kingdom 1
Puerto Rico 1
Russian Federation 1
Serbia 1
Thailand 1
Turkey 1
Ukraine|United States|Bulgaria|India|Malaysia|Philippines|Romania|South Africa 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Croatia|Czech Republic|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Taiwan 1
United States|Argentina|Canada|Czech Republic|Estonia|France|Hungary|Latvia|Lithuania 1
United States|Argentina|Russian Federation 1
United States|Austria|Belgium|Canada|France|India|Italy|Poland|Portugal|Russian Federation|Serbia|Sweden|Ukraine|United Kingdom 1
United States|Austria|Belgium|Italy|Poland|Portugal|Serbia|Spain|Sweden 1
United States|Austria|Bulgaria|Ireland|Israel|Italy|Poland|Puerto Rico|Serbia|Ukraine|United Kingdom 1
United States|Austria|Germany|Ireland|Israel|Italy|Poland|Spain|Ukraine|United Kingdom 1
United States|Belgium|Bulgaria|Estonia|Finland|India|Korea, Republic of|Poland|Romania|Russian Federation|Ukraine 1
United States|Brazil|Germany|Greece|Spain|Turkey 1
United States|Brazil|Israel|Korea, Republic of|Mexico|Puerto Rico|Russian Federation 1
United States|Brazil|Mexico 1
United States|Brazil|United Kingdom 1
United States|Bulgaria|Chile|Czechia|France|Germany|Italy|Poland|Serbia|Slovakia|Spain|Ukraine|United Kingdom 1
United States|Bulgaria|France|India|Russian Federation|Ukraine|United Kingdom 1
United States|Canada|China|United Kingdom 1
United States|Canada|Mexico|Netherlands|Puerto Rico 1
United States|Egypt|India 1
United States|India|Italy 1
United States|India|Korea, Republic of|Malaysia|Philippines|Romania 1
United States|India|Malaysia|Moldova, Republic of|Philippines 1
United States|India|Romania 1
United States|Israel 1
United States|Puerto Rico 1
Zimbabwe 1

Sites per Study

Site_count Study_Count
1 563
2 67
3 25
4 25
5 10
6 4
7 5
8 10
9 3
10 3
11 3
12 1
13 4
14 1
15 5
16 3
17 2
18 2
19 3
21 6
22 1
23 1
24 2
25 2
26 2
27 3
28 1
30 1
32 1
33 3
34 2
38 1
39 1
41 2
43 1
44 2
48 1
50 1
51 2
53 1
54 2
63 1
64 1
72 1
73 1
78 1
83 1
84 1
92 1
98 1
122 1
135 1

Phase

Phase Study_Count
N/A 368
Phase 4 158
Phase 3 89
Phase 2 81
Phase 1 57
Phase 1/Phase 2 14
Phase 2/Phase 3 14
Early Phase 1 8

Number of Arms

Number_of_Arms Count_of_Studies
1 109
2 453
3 78
4 27
5 4
6 3
7 1
9 2
NA 112

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 18.000 1.0000 9.00000 17.00 2.00000 27.0000 1.0000 10.0000
1st Qu. 30.000 40.0000 24.75000 30.75 38.25000 63.0000 103.0000 40.0000
Median 39.000 76.0000 43.50000 44.00 60.50000 120.0000 258.0000 75.5000
Mean 77.875 147.1311 66.69643 57.50 91.26923 119.9286 288.2273 134.8205
3rd Qu. 69.750 160.7500 77.75000 60.00 100.00000 146.0000 394.0000 180.0000
Max. 324.000 2796.0000 305.00000 160.00 500.00000 240.0000 1579.0000 1098.0000

Trial Group Type

group_type Group_Count
Experimental 670
Active Comparator 386
Placebo Comparator 177
NA 112
No Intervention 84
Other 77
Sham Comparator 26

Intervention Model

intervention_model Study_Count
Parallel Assignment 559
Single Group Assignment 158
Crossover Assignment 44
Factorial Assignment 16
NA 8
Sequential Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 609
Health Services Research 37
Other 33
Prevention 31
Supportive Care 26
Basic Science 25
NA 17
Diagnostic 6
Screening 5

Observational Studies

Studies by Country

Country Study_Count
United States 39
NA 15
Canada 10
Germany 8
Spain 7
France 4
Norway 4
China 3
Hong Kong 3
Australia 2
Korea, Republic of 2
Sweden 2
Switzerland 2
United Kingdom 2
Austria 1
Austria|Finland|Germany|Netherlands 1
Belgium 1
Brazil 1
Croatia 1
Denmark 1
Germany|Greece|Netherlands|Spain 1
Israel 1
Italy 1
Netherlands 1
Russian Federation 1
Taiwan 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 95
2 7
3 7
4 2
5 1
9 1
11 1
14 1
76 1

Enrollment Metrics

Measure Observational
Min 4.000
1st Qu 49.750
Median 106.000
Mean 7381.759
3rd Qu 373.000
Max 725489.000

Observation Model

observational_model Study_Count
Cohort 37
Case-Only 28
Case-Control 20
NA 14
Case Control 7
Other 5
Ecologic or Community 2
Family-Based 2
Defined Population 1

Time Perspective

time_perspective Study_Count
Prospective 61
Cross-Sectional 28
Retrospective 14
Other 10
NA 2
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 3
China 2
Finland 1
France 1
NA 1
Spain 1

Sites per Study

Site_count Study_Count
1 8
3 1

Enrollment Metrics

Measure Registries
Min 30.0
1st Qu 160.0
Median 300.0
Mean 660585.1
3rd Qu 1000.0
Max 5940299.0

Registry Model

observational_model Study_Count
Cohort 6
Case-Control 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 7
Cross-Sectional 2

Follow-up

target_duration Study_Count
1 Year 1
15 Months 1
17 Years 1
2 Days 1
2 Weeks 1
24 Months 1
3 Years 1
5 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03369730 Reducing the Duration of Untreated Psychosis in the United States https://ClinicalTrials.gov/show/NCT03369730 Recruiting Icahn School of Medicine at Mount Sinai 2020-09-15
NCT03820362 The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique https://ClinicalTrials.gov/show/NCT03820362 Completed University of Barcelona 2018-11-30
NCT00001486 Genetic Study of Schizophrenia https://ClinicalTrials.gov/show/NCT00001486 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03271242 Implementation of National Guidelines for Treatment of Psychoses https://ClinicalTrials.gov/show/NCT03271242 Completed University Hospital, Akershus 2018-12-31
NCT03253367 Phenomics and Genomics of Clozapine Pharmacotherapy https://ClinicalTrials.gov/show/NCT03253367 Recruiting UMC Utrecht 2021-12-31
NCT03248180 Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States https://ClinicalTrials.gov/show/NCT03248180 Recruiting National Taiwan University Hospital 2020-12-31
NCT03235908 Copeptin in Outcome Prediction of an Acute Psychotic Episode https://ClinicalTrials.gov/show/NCT03235908 Active, not recruiting University Hospital, Basel, Switzerland 2020-07-31
NCT03166098 The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders https://ClinicalTrials.gov/show/NCT03166098 Active, not recruiting NYU Langone Health 2020-11-30
NCT03152292 The INSYTE (Management of Parkinson’s Disease Psychosis in Actual Practice) Study https://ClinicalTrials.gov/show/NCT03152292 Recruiting ACADIA Pharmaceuticals Inc. 2021-09-30
NCT03102151 Reducing the Duration of Untreated Psychosis https://ClinicalTrials.gov/show/NCT03102151 Active, not recruiting University of Southern California 2019-08-30
NCT03076346 Neural Biomarkers of Clozapine Response https://ClinicalTrials.gov/show/NCT03076346 Recruiting University of Pittsburgh 2020-06-30
NCT03049800 Is Cognitive Training Neuroprotective in Early Psychosis? https://ClinicalTrials.gov/show/NCT03049800 Recruiting University of Minnesota 2020-06-12
NCT02921243 Schizophrenia and the Gut Microbiome https://ClinicalTrials.gov/show/NCT02921243 Completed University of Maryland, Baltimore 2019-06-18
NCT02916303 Cost-effectiveness of Interventions in First-episode Psychosis https://ClinicalTrials.gov/show/NCT02916303 Enrolling by invitation Fundación Marques de Valdecilla 2017-07-31
NCT02897167 Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients https://ClinicalTrials.gov/show/NCT02897167 Completed Fundación Marques de Valdecilla 2018-12-31
NCT02822092 Striatal Connectivity and Clinical Outcome in Psychosis https://ClinicalTrials.gov/show/NCT02822092 Recruiting Northwell Health 2021-10-31
NCT02782507 Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study https://ClinicalTrials.gov/show/NCT02782507 Completed Newcastle University 2013-12-31
NCT02775864 Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia https://ClinicalTrials.gov/show/NCT02775864 Completed New York State Psychiatric Institute 2018-04-30
NCT02739932 Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study https://ClinicalTrials.gov/show/NCT02739932 Active, not recruiting University of Calgary 2021-08-31
NCT02693327 Microbiome and the Gut-Brain Axis https://ClinicalTrials.gov/show/NCT02693327 Completed University of Florida 2017-09-30
NCT02582736 Antipsychotics and Risk of Hyperglycemic Emergencies https://ClinicalTrials.gov/show/NCT02582736 Completed Canadian Network for Observational Drug Effect Studies, CNODES 2012-12-31
NCT00942981 Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography https://ClinicalTrials.gov/show/NCT00942981 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02034253 Glutamate, Brain Connectivity and Duration of Untreated Psychosis https://ClinicalTrials.gov/show/NCT02034253 Completed University of Alabama at Birmingham 2018-11-30
NCT02505022 Role Functioning Changes NOS https://ClinicalTrials.gov/show/NCT02505022 Recruiting Northwestern University 2021-01-31
NCT02483130 Effect of N-acetylcysteine on Brain Glutamate https://ClinicalTrials.gov/show/NCT02483130 Completed King’s College London 2017-02-28
NCT02401984 Zurcher Adolescent Screening for Mental Disorder https://ClinicalTrials.gov/show/NCT02401984 Completed Zurich University of Applied Sciences 2015-07-31
NCT02321943 Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study https://ClinicalTrials.gov/show/NCT02321943 Completed Sykehuset Innlandet HF 2016-12-31
NCT02218853 Psychosis and Affective Research Domains and Intermediate Phenotypes https://ClinicalTrials.gov/show/NCT02218853 Completed University of Texas Southwestern Medical Center 2017-06-30
NCT01309373 An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT01309373 Completed Janssen-Cilag, S.A. NA
NCT01269710 Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study https://ClinicalTrials.gov/show/NCT01269710 Completed University of North Carolina, Chapel Hill 2011-03-31
NCT02009826 Psychosis-Associated Neuroinflammation in Schizophrenia https://ClinicalTrials.gov/show/NCT02009826 Completed Universiteit Antwerpen 2017-02-28
NCT01924715 Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study https://ClinicalTrials.gov/show/NCT01924715 Completed Nova Scotia Health Authority 2009-03-31
NCT01786369 Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. https://ClinicalTrials.gov/show/NCT01786369 Completed Northwell Health 2015-04-30
NCT01754532 Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels https://ClinicalTrials.gov/show/NCT01754532 Completed Shalvata Mental Health Center 2015-06-30
NCT01753284 First Episode Psychosis and Pathway to Care in Nordland https://ClinicalTrials.gov/show/NCT01753284 Completed Nordlandssykehuset HF 2018-10-31
NCT01739127 Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI https://ClinicalTrials.gov/show/NCT01739127 Completed University of British Columbia 2016-02-29
NCT01701765 Outcomes and Discharge of Long-stay Psychiatric Patients https://ClinicalTrials.gov/show/NCT01701765 Completed IRCCS Centro San Giovanni di Dio Fatebenefratelli 2011-01-31
NCT01695395 Mental Health Care Provision for Adults With Intellectual Disability and a Mental Disorder https://ClinicalTrials.gov/show/NCT01695395 Completed Technische Universität Dresden 2014-04-30
NCT01569347 Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers https://ClinicalTrials.gov/show/NCT01569347 Completed Assistance Publique - Hôpitaux de Paris 2016-11-30
NCT01518049 Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD) https://ClinicalTrials.gov/show/NCT01518049 Completed Aarhus University Hospital 2013-09-30
NCT01480037 Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging https://ClinicalTrials.gov/show/NCT01480037 Completed Associação Fundo de Incentivo à Pesquisa 2011-06-30
NCT01425684 Brain Circuits in Schizophrenia and Smoking https://ClinicalTrials.gov/show/NCT01425684 Recruiting University of Maryland, Baltimore 2020-01-31
NCT01425671 Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States https://ClinicalTrials.gov/show/NCT01425671 Active, not recruiting University of Maryland, Baltimore 2020-01-31
NCT01409109 Database Registry for Neural Network Biomarkers in Psychosis https://ClinicalTrials.gov/show/NCT01409109 Active, not recruiting University of Texas Southwestern Medical Center 2023-05-31
NCT01392885 Brain Health and Exercise in Schizophrenia https://ClinicalTrials.gov/show/NCT01392885 Enrolling by invitation BC Mental Health and Addictions Research Institute 2016-06-30
NCT01385709 The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels https://ClinicalTrials.gov/show/NCT01385709 Completed Weill Medical College of Cornell University 2012-08-31
NCT01384604 Neurophysiological Studies in Schizophrenia and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT01384604 Completed University of Texas Southwestern Medical Center 2013-05-31
NCT04369677 Thermoregulation Among Individuals With First-episode Psychosis https://ClinicalTrials.gov/show/NCT04369677 Recruiting Ohio State University 2021-04-03
NCT04335916 Survey on Pre-ECT Evaluation and ECT Application https://ClinicalTrials.gov/show/NCT04335916 Recruiting Klinički Bolnički Centar Zagreb 2020-09-01
NCT04304417 The Role of Group Identity on the Community Integration of People With Severe Mental Disorder https://ClinicalTrials.gov/show/NCT04304417 Recruiting Universidad Complutense de Madrid 2020-03-31
NCT04280367 Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age https://ClinicalTrials.gov/show/NCT04280367 Recruiting Assistance Publique - Hôpitaux de Paris 2021-02-28
NCT04200300 Professional Quality of Life in German Mental Health Nursing https://ClinicalTrials.gov/show/NCT04200300 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04200274 Physical Activity Recommendation Behaviour in German Mental Health Nurses https://ClinicalTrials.gov/show/NCT04200274 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04165733 Professional Quality of Life in German Psychiatrists https://ClinicalTrials.gov/show/NCT04165733 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04165720 Physical Activity Recommendation Behaviour in German Psychiatrists https://ClinicalTrials.gov/show/NCT04165720 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04149912 Professional Quality of Life in German Psychologists https://ClinicalTrials.gov/show/NCT04149912 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04149795 Physical Activity Recommendation Behaviour in German Psychologists https://ClinicalTrials.gov/show/NCT04149795 Recruiting Charite University, Berlin, Germany 2020-12-31
NCT04051775 Non-Pharmacological Treatment of Psychosis https://ClinicalTrials.gov/show/NCT04051775 Recruiting Haukeland University Hospital 2022-06-30
NCT04024371 Validating Reward-related Biomarkers (RTOC) https://ClinicalTrials.gov/show/NCT04024371 Recruiting Maastricht University 2020-08-01
NCT04021719 OnTrackNY’s Learning Healthcare System https://ClinicalTrials.gov/show/NCT04021719 Recruiting New York State Psychiatric Institute 2024-07-30
NCT03999931 Study on the Difference of Plasma microRNA Expression in Patients With Genetic Susceptibility to Mental Disorders https://ClinicalTrials.gov/show/NCT03999931 Completed Second Affiliated Hospital, School of Medicine, Zhejiang University 2015-01-01
NCT03995121 SV2 PET Imaging With [11C]APP311 https://ClinicalTrials.gov/show/NCT03995121 Active, not recruiting Yale University 2023-12-31
NCT03984084 Biological Classification of Mental Disorders https://ClinicalTrials.gov/show/NCT03984084 Recruiting Max-Planck-Institute of Psychiatry 2025-12-31
NCT03965598 Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group https://ClinicalTrials.gov/show/NCT03965598 Recruiting Second Xiangya Hospital of Central South University 2021-12-31
NCT03932188 Brain Imaging in Early Psychosis https://ClinicalTrials.gov/show/NCT03932188 Recruiting Washington University School of Medicine 2021-04-30
NCT03919760 Early Psychosis Intervention - Spreading Evidence-based Treatment https://ClinicalTrials.gov/show/NCT03919760 Recruiting Centre for Addiction and Mental Health 2023-05-31
NCT03774641 A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women https://ClinicalTrials.gov/show/NCT03774641 Recruiting Johns Hopkins University 2020-12-31
NCT03689296 Patient-caregiver Collaboration for Better Cardiovascular Care for Patients With Long-term Mental Disorders: Multicentre Qualitative and Feasibility Studies https://ClinicalTrials.gov/show/NCT03689296 Recruiting Centre Hospitalier Universitaire Dijon 2021-12-31
NCT00836251 Effects of Antipsychotic Medications on Energy Intake and Expenditure https://ClinicalTrials.gov/show/NCT00836251 Completed Washington University School of Medicine 2008-06-30
NCT03558529 Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse https://ClinicalTrials.gov/show/NCT03558529 Completed Manchester Academic Health Science Centre 2018-04-01
NCT03525054 Semantic and Syntactic Computerized Analysis of Free Speech https://ClinicalTrials.gov/show/NCT03525054 Recruiting University Hospital, Brest 2022-05-18
NCT03501160 Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers’ Perspective https://ClinicalTrials.gov/show/NCT03501160 Active, not recruiting Chinese University of Hong Kong 2020-04-30
NCT03485339 Substance Misuse To Psychosis for Ketamine (SToP-K) https://ClinicalTrials.gov/show/NCT03485339 Active, not recruiting The University of Hong Kong 2020-06-05
NCT03481465 Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis https://ClinicalTrials.gov/show/NCT03481465 Enrolling by invitation Fundación Marques de Valdecilla 2019-12-31
NCT03476473 Early Detection of Respiratory Disorders in Psychosis https://ClinicalTrials.gov/show/NCT03476473 Enrolling by invitation Fundación Marques de Valdecilla 2018-03-26
NCT03449407 Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis https://ClinicalTrials.gov/show/NCT03449407 Completed Chinese University of Hong Kong 2019-06-30
NCT03414151 Gut Microbiome in AP Naive https://ClinicalTrials.gov/show/NCT03414151 Recruiting Centre for Addiction and Mental Health 2022-03-31
NCT01196858 Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland https://ClinicalTrials.gov/show/NCT01196858 Completed University Hospital of North Norway 2013-09-30
NCT01092598 Factors Association With Poor Physical Function in Older Adults With Schizophrenia https://ClinicalTrials.gov/show/NCT01092598 Completed University of California, San Francisco 2012-06-30
NCT01043250 Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients https://ClinicalTrials.gov/show/NCT01043250 Completed Samsung Medical Center 2010-04-30
NCT01036568 Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia https://ClinicalTrials.gov/show/NCT01036568 Completed National Institutes of Health Clinical Center (CC) NA
NCT01028196 Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression https://ClinicalTrials.gov/show/NCT01028196 Completed AstraZeneca 2010-11-30
NCT01011088 Paternal Psychosis After Baby Born https://ClinicalTrials.gov/show/NCT01011088 Completed Nanjing Medical University 2010-05-31
NCT01001481 Schizophrenia Treatment Adherence Investigation (STAI) https://ClinicalTrials.gov/show/NCT01001481 Completed Janssen-Cilag Pty Ltd 2009-09-30
NCT00913731 Quality Project to Evaluate and Validate the FAST-O Rating Scale https://ClinicalTrials.gov/show/NCT00913731 Completed AstraZeneca NA
NCT00903916 Effect of Antipsychotics on Appetite Regulation https://ClinicalTrials.gov/show/NCT00903916 Completed University of North Carolina, Chapel Hill 2012-03-31
NCT00894738 Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures https://ClinicalTrials.gov/show/NCT00894738 Completed Washington University School of Medicine 2016-03-31
NCT00872313 Risk Factors for Postpartum Psychosis https://ClinicalTrials.gov/show/NCT00872313 Completed Nanjing Medical University 2012-08-31
NCT00780585 A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED) https://ClinicalTrials.gov/show/NCT00780585 Completed Merck Sharp & Dohme Corp. 2009-01-31
NCT00749970 Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00749970 Completed AstraZeneca 2009-01-31
NCT00691535 Genetics of Symptomatology and Treatment Response in Psychotic Major Depression https://ClinicalTrials.gov/show/NCT00691535 Completed Stanford University 2012-06-30
NCT00683709 Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder https://ClinicalTrials.gov/show/NCT00683709 Completed St. Joseph’s Healthcare Hamilton 2011-07-31
NCT00680888 Adherence in Adolescents and Children Treated on Quetiapine https://ClinicalTrials.gov/show/NCT00680888 Completed AstraZeneca 2008-08-31
NCT00670371 Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study https://ClinicalTrials.gov/show/NCT00670371 Completed AstraZeneca NA
NCT00644852 Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone https://ClinicalTrials.gov/show/NCT00644852 Completed Johnson & Johnson Taiwan Ltd 2007-09-30
NCT00627510 Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission https://ClinicalTrials.gov/show/NCT00627510 Completed Medical University Innsbruck 2005-07-31
NCT00579267 Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) https://ClinicalTrials.gov/show/NCT00579267 Completed University of South Florida 2008-01-31
NCT00576095 Clinical and Biological Characteristics of Psychotic Depression https://ClinicalTrials.gov/show/NCT00576095 Completed Stanford University 2012-06-30
NCT00538122 Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment https://ClinicalTrials.gov/show/NCT00538122 Completed Vanderbilt University 2008-07-31
NCT00523783 Seroquel Long-Term NIS for Schizophrenia Patients https://ClinicalTrials.gov/show/NCT00523783 Completed AstraZeneca 2007-11-30
NCT00458367 RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT00458367 Completed Janssen Pharmaceutica N.V., Belgium NA
NCT00454883 Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders. https://ClinicalTrials.gov/show/NCT00454883 Completed Pfizer 2007-12-31
NCT00448331 Facilitated Referral for Children Screening Positive for Mental Illness https://ClinicalTrials.gov/show/NCT00448331 Completed Children’s Hospital Medical Center, Cincinnati NA
NCT00399334 PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders https://ClinicalTrials.gov/show/NCT00399334 Completed Janssen-Cilag, S.A. NA
NCT00377117 Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II https://ClinicalTrials.gov/show/NCT00377117 Completed Lawson Health Research Institute NA
NCT00350493 Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness https://ClinicalTrials.gov/show/NCT00350493 Completed The University of New South Wales 2006-02-28
NCT00312598 Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine https://ClinicalTrials.gov/show/NCT00312598 Completed University of North Carolina, Chapel Hill 2010-04-30
NCT00291200 Enhancing the Prospective Prediction of Psychosis https://ClinicalTrials.gov/show/NCT00291200 Completed Yale University 2009-02-28
NCT00283517 A Registry of Treatment Adherence for Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00283517 Completed Janssen-Cilag, S.A. NA
NCT00253240 Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population https://ClinicalTrials.gov/show/NCT00253240 Completed Lawson Health Research Institute NA
NCT00222807 Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00222807 Completed University of Pittsburgh 2016-03-31
NCT00184418 The Immune System and Psychiatric Disorders https://ClinicalTrials.gov/show/NCT00184418 Completed Norwegian University of Science and Technology 2008-01-31
NCT00163865 A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents https://ClinicalTrials.gov/show/NCT00163865 Completed Bayside Health 2008-06-30
NCT00161057 Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment https://ClinicalTrials.gov/show/NCT00161057 Completed UMC Utrecht NA
NCT00135772 Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 https://ClinicalTrials.gov/show/NCT00135772 Completed National Institute on Drug Abuse (NIDA) 2004-07-31
NCT00070889 Brain Cell Injury in Patients With A First Episode of Psychosis https://ClinicalTrials.gov/show/NCT00070889 Completed National Center for Complementary and Integrative Health (NCCIH) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03332966 Youth Experiences and Health Study https://ClinicalTrials.gov/show/NCT03332966 Recruiting National Institute for Health and Welfare, Finland 2024-12-31
NCT02873884 Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT) https://ClinicalTrials.gov/show/NCT02873884 Recruiting University Hospital, Caen 2019-11-30
NCT02200588 Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP https://ClinicalTrials.gov/show/NCT02200588 Enrolling by invitation Fundación Marques de Valdecilla 2017-12-31
NCT04444180 The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis https://ClinicalTrials.gov/show/NCT04444180 Recruiting Shanghai Mental Health Center 2020-11-30
NCT04010864 A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study) https://ClinicalTrials.gov/show/NCT04010864 Recruiting Shanghai Mental Health Center 2022-12-31
NCT03970005 Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis https://ClinicalTrials.gov/show/NCT03970005 Enrolling by invitation Ohio State University 2024-04-30
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT01246765 National Pregnancy Registry for Atypical Antipsychotics https://ClinicalTrials.gov/show/NCT01246765 Recruiting Massachusetts General Hospital 2022-12-31
NCT00762866 Psychiatric Genotype/Phenotype Project Repository https://ClinicalTrials.gov/show/NCT00762866 Enrolling by invitation Vanderbilt University Medical Center 2020-12-31